Research Article

Estimation of Antioxidant Levels in Saliva and Serum of Chronic Periodontitis Patients with and without Ischemic Heart Disease

Table 3

Comparison of salivary levels.

AntioxidantGroupMean (SD)Median (Q1–Q3)-value# (df) value

Saliva TAC (mM/L)IHD + CP200.42 (0.17)0.37 (0.26–0.60)3.921 (3)0.270 (NS)
CP200.44 (0.14)0.40 (0.33–0.50)
IHD + H200.41 (0.18)0.34 (0.32–0.38)
H200.48 (0.18)0.53 (0.36–0.56)

Saliva SOD (U/mg protein)IHD + CP2027.60 (8.37)25.60 (20.70–32.03)4.939 (3)0.176 (NS)
CP2026.34 (9.08)24.61 (18.72–33.47)
IHD + H2030.10 (6.25)31.51 (30.58–32.89)
H2032.78 (11.76)33.15 (22.48–44.33)

Saliva GPx (g/g protein)IHD + CP200.39 (0.10)0.37 (0.29–0.46)17.230 (3)0.001
CP200.38 (0.09)0.38 (0.30–0.46)
IHD + H200.44 (0.05)0.46 (0.40–0.47)
H200.34 (0.06)0.35 (0.30–0.35)

Saliva CAT (U/mg protein)IHD + CP2020.34 (3.92)20.02 (17.72–22.82)7.449 (3)0.059 (NS)
CP2021.11 (5.71)21.49 (15.71–25.50)
IHD + H2023.74 (3.71)25.48 (20.00–26.51)
H2021.91 (5.24)23.75 (16.98–26.24)

Kruskal–Wallis test; , statistically significant; , nonsignificant (NS).